A novel triple therapy shows promise for advanced triple-negative breast cancer, offering hope for patients with limited ...

Mersana Therapeutics Inc. (NASDAQ: MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana Therapeutics presented additional positive interim Phase 1 clinical data for ...

A new study from ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & ...

No one wants to hear the words: "You have cancer." But about 1 in 8 American women will learn they have breast cancer, according to the Centers for Disease Control and Prevention. "Breast ...

These data support the use of sacituzumab plus pembrolizumab as a potential new standard of care,” said Sara Tolaney, MD.

The study was published in the journal Molecular Cancer Research. It shows that insulin resistance—a condition linked to Type ...

If you’re a cancer survivor, there’s no reason to be alone. Join the many amazing women and “a few awesome men” by becoming one of Shay’s Warriors. Visit shayswarriors.org or call 760-895-1705 for ...

Tyler Bremner was picked by the Angels on July 13. Three days earlier, his family had held a celebration of life for his ...

Researchers who conducted a real-world analysis of trastuzumab deruxtecan found the drug to be effective in treating metastatic breast cancer, though survival outcomes did not reach clinical trial ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

Research from the University of Notre Dame is shedding light on why Black women are likely to have early-onset or more ...

Among a cohort of 1,135 women ages 40 and younger with stage I through III breast cancer, the incidence of LRR was 5.6%, with ...